Literature DB >> 10468046

Transient monocyte release of interleukin-10 in response to traumatic brain injury.

R Shimonkevitz1, D Bar-Or, L Harris, K Dole, L McLaughlin, R Yukl.   

Abstract

A significant component of the immune response to trauma results in the systemic presence of cytokines which have the potential to suppress the patient's immune response to infection and contribute to post-injury complications. We assayed peripheral blood leukocytes obtained from 10 patients with head trauma to determine their production of interleukin (IL). Serum was assayed for the presence of IL-10, TGFbeta1, and IFNgamma by ELISA. Peripheral blood leukocytes were screened for intracellular IL-10 and IFNgamma by fluorescence-activated flow cytometry, and cytokine-specific mRNA was detected by the polymerase chain reaction. We detected an immediate, but transient, presence of IL-10 in the sera of all 10 patients who suffered head trauma. IL-10-specific intracytoplasmic immunofluorescence was also detected immediately after injury in peripheral blood monocytes, but not in lymphocytes or granulocytes. IL-10-specific mRNA was detected in peripheral blood leukocytes in only 50% of patients immediately after injury, when the highest serum levels of IL-10 were observed. Our data indicates that release of pre-formed IL-10 by monocytes contributes to the presence of IL-10 found in patient peripheral blood immediately after head injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468046     DOI: 10.1097/00024382-199907000-00002

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  9 in total

Review 1.  Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift.

Authors:  Yasir N Jassam; Saef Izzy; Michael Whalen; Dorian B McGavern; Joseph El Khoury
Journal:  Neuron       Date:  2017-09-13       Impact factor: 17.173

2.  Acute, regional inflammatory response after traumatic brain injury: Implications for cellular therapy.

Authors:  Matthew T Harting; Fernando Jimenez; Sasha D Adams; David W Mercer; Charles S Cox
Journal:  Surgery       Date:  2008-08-10       Impact factor: 3.982

3.  The acute inflammatory response in trauma / hemorrhage and traumatic brain injury: current state and emerging prospects.

Authors:  R Namas; A Ghuma; L Hermus; R Zamora; D O Okonkwo; T R Billiar; Y Vodovotz
Journal:  Libyan J Med       Date:  2009-09-01       Impact factor: 1.657

Review 4.  Endogenous repair signaling after brain injury and complementary bioengineering approaches to enhance neural regeneration.

Authors:  Caroline P Addington; Adam Roussas; Dipankar Dutta; Sarah E Stabenfeldt
Journal:  Biomark Insights       Date:  2015-05-12

Review 5.  Role of Interleukin-10 in Acute Brain Injuries.

Authors:  Joshua M Garcia; Stephanie A Stillings; Jenna L Leclerc; Harrison Phillips; Nancy J Edwards; Steven A Robicsek; Brian L Hoh; Spiros Blackburn; Sylvain Doré
Journal:  Front Neurol       Date:  2017-06-12       Impact factor: 4.003

6.  The role of markers of inflammation in traumatic brain injury.

Authors:  Thomas Woodcock; Maria Cristina Morganti-Kossmann
Journal:  Front Neurol       Date:  2013-03-04       Impact factor: 4.003

Review 7.  Nosocomial infections and immunity: lesson from brain-injured patients.

Authors:  Tomasz Dziedzic; Agnieszka Slowik; Andrzej Szczudlik
Journal:  Crit Care       Date:  2004-02-19       Impact factor: 9.097

Review 8.  Traumatic Brain Injury and Peripheral Immune Suppression: Primer and Prospectus.

Authors:  Jon Hazeldine; Janet M Lord; Antonio Belli
Journal:  Front Neurol       Date:  2015-11-05       Impact factor: 4.003

9.  Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury.

Authors:  Alex P Di Battista; Shawn G Rhind; Michael G Hutchison; Syed Hassan; Maria Y Shiu; Kenji Inaba; Jane Topolovec-Vranic; Antonio Capone Neto; Sandro B Rizoli; Andrew J Baker
Journal:  J Neuroinflammation       Date:  2016-02-16       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.